Selexagen Therapeutics Overview

  • Founded
  • 2008
Founded
  • Status
  • Out of Business
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Out of Business

Selexagen Therapeutics General Information

Description

Developer of therapeutic drugs created to treat cancer. The company's drugs utilizes molecular modeling and structure based drug design technologies, enabling physicians to offer clinical trials in cancer patients.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 4653 Carmel Mountain Road
  • Suite 308-330
  • San Diego, CA 92130
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Selexagen Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 12-Sep-2016 00000 Completed Out of Business
1. Angel (individual) 22-Jul-2011 00000 00000 Completed Startup
To view Selexagen Therapeutics’s complete valuation and funding history, request access »

Selexagen Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Jean-Michel Vernier Ph.D Vice President, Chemistry
You’re viewing 1 of 6 executive team members. Get the full list »

Selexagen Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial